What if I had invested $1,000 in Biomarin Pharmaceutical Inc in 2014?

What if I had invested? › Biomarin Pharmaceutical Inc

$1,000 in Biomarin Pharmaceutical Inc in 2014

$1,000 put into Biomarin Pharmaceutical Inc (BMRN) on January 2, 2014, its first trading day of 2014 in our data, was worth $898 on September 23, 2026, with dividends counted to the end of 2024. Over the same days to July 31, 2026, $1,000 in the whole US stock market became $4,939.

$1,000 became$898by September 23, 2026

Total return-10.2%dividends counted to 2024

A year, on average-0.8%over 12.7 years

The whole US market$4,939same days to July 31, 2026, dividends counted; BMRN by then: $866

The S&P 500 index$4,206price only, no dividends

Bought at the close on January 2, 2014, dividends put back in, no costs and no tax. Dividends are counted to the end of 2024; from 2025 on our prices are adjusted for splits only, so dividends paid since then are left out. The stock figure counts dividends; the S&P 500 index figure does not, so compare the stock with the whole-market figure. The market figure is the Fama-French US market return (Kenneth R. French data library), which runs to July 31, 2026. Our stock prices run to September 23, 2026.

Another stock, another year

Biomarin Pharmaceutical Inc in: 1999 · 2000 · 2001 · 2002 · 2003 · 2004 · 2005 · 2006 · 2007 · 2008 · 2009 · 2010 · 2011 · 2012 · 2013 · 2015 · 2016 · 2017 · 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Also in 2014

Nvidia · $1,000 became $602,934
Apple Inc. · $1,000 became $19,555
Microsoft · $1,000 became $16,115
Amazon · $1,000 became $12,527
Alphabet Inc. (Class A) · $1,000 became $12,165
Avago Technologies · $1,000 became $88,599
Alphabet Inc. - Class C Capital Stock · $1,000 became $12,068
Meta Platforms · $1,000 became $13,652

Ask the Lab what the market did next

History, not advice. How these numbers are made.